ZA906839B - Fusion proteins,their preparation and use - Google Patents
Fusion proteins,their preparation and useInfo
- Publication number
- ZA906839B ZA906839B ZA906839A ZA906839A ZA906839B ZA 906839 B ZA906839 B ZA 906839B ZA 906839 A ZA906839 A ZA 906839A ZA 906839 A ZA906839 A ZA 906839A ZA 906839 B ZA906839 B ZA 906839B
- Authority
- ZA
- South Africa
- Prior art keywords
- fusion proteins
- manner
- preparation
- fusion protein
- oligonucleotide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Plant Pathology (AREA)
- Endocrinology (AREA)
- Microbiology (AREA)
- Diabetes (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39987489A | 1989-08-29 | 1989-08-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA906839B true ZA906839B (en) | 1991-06-26 |
Family
ID=23581315
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA906839A ZA906839B (en) | 1989-08-29 | 1990-09-28 | Fusion proteins,their preparation and use |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0489780B1 (no) |
JP (1) | JP3043803B2 (no) |
KR (1) | KR0159786B1 (no) |
AT (1) | ATE173018T1 (no) |
AU (1) | AU638277B2 (no) |
CA (1) | CA2065146C (no) |
CY (1) | CY2168B1 (no) |
DE (1) | DE69032743T2 (no) |
DK (1) | DK0489780T3 (no) |
ES (1) | ES2124216T3 (no) |
FI (1) | FI113183B (no) |
GR (1) | GR1005153B (no) |
HK (1) | HK1012026A1 (no) |
HU (1) | HU216069B (no) |
IE (1) | IE903120A1 (no) |
IL (1) | IL95495A (no) |
NO (1) | NO308667B1 (no) |
PT (1) | PT95111B (no) |
WO (1) | WO1991003550A1 (no) |
ZA (1) | ZA906839B (no) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5426036A (en) * | 1987-05-05 | 1995-06-20 | Hoechst Aktiengesellschaft | Processes for the preparation of foreign proteins in streptomycetes |
ES2097426T3 (es) * | 1992-12-02 | 1997-04-01 | Hoechst Ag | Procedimiento para la obtencion de proinsulina con puentes de cistina correctamente unidos. |
DE59409816D1 (de) * | 1993-04-27 | 2001-09-13 | Hoechst Ag | Amorphe monosphärische Formen von Insulinderivaten |
EP0672753B1 (en) * | 1993-10-05 | 2008-01-02 | Asahi Glass Company Ltd. | Multicloning vector, expression vector, and production of foreign protein with expression vector |
US6001604A (en) * | 1993-12-29 | 1999-12-14 | Bio-Technology General Corp. | Refolding of proinsulins without addition of reducing agents |
DE4405179A1 (de) * | 1994-02-18 | 1995-08-24 | Hoechst Ag | Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken |
US5683987A (en) * | 1994-07-12 | 1997-11-04 | The Board Of Regents Of The University Of Nebraska | Therapeutic oligonucleotides targeting the human MDR1 and MRP genes |
ATE264871T1 (de) | 1996-07-26 | 2004-05-15 | Aventis Pharma Gmbh | Insulinderivate mit erhöhter zinkbindung |
DE19735711C2 (de) * | 1997-08-18 | 2001-04-26 | Aventis Pharma Gmbh | Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken |
DE19825447A1 (de) | 1998-06-06 | 1999-12-09 | Hoechst Marion Roussel De Gmbh | Neue Insulinanaloga mit erhöhter Zinkbildung |
DE19915938A1 (de) | 1999-04-09 | 2000-10-19 | Aventis Pharma Gmbh | Herstellung von pankreatischer Procarboxypeptidase B, Isoformen und Muteinen davon und ihre Verwendung |
DE19930676B4 (de) | 1999-07-02 | 2006-01-19 | Sanofi-Aventis Deutschland Gmbh | Verfahren zur Stabilisierung von Insulin, Insulinderivaten und/oder deren Vorläufer in komplexen Mischungen bei deren Lagerung in wäßrigen Lösungsmitteln |
US7202059B2 (en) | 2001-02-20 | 2007-04-10 | Sanofi-Aventis Deutschland Gmbh | Fusion proteins capable of being secreted into a fermentation medium |
US7638618B2 (en) | 2001-02-20 | 2009-12-29 | Sanofi-Aventis Deutschland Gmbh | Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest |
DE10235168A1 (de) * | 2002-08-01 | 2004-02-12 | Aventis Pharma Deutschland Gmbh | Verfahren zur Reinigung von Preproinsulin |
WO2004044206A1 (en) * | 2002-11-12 | 2004-05-27 | Ckd Bio Corp. | Plasmids expressing human insulin and the preparation method for human insuling thereby |
DE102008003568A1 (de) | 2008-01-09 | 2009-07-16 | Sanofi-Aventis Deutschland Gmbh | Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil |
CN102007143B (zh) | 2008-01-09 | 2015-08-26 | 塞诺菲-安万特德国有限公司 | 具有超延迟时效特征的新型胰岛素衍生物 |
JP5695909B2 (ja) | 2008-01-09 | 2015-04-08 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 極度に遅延した時間作用プロファイルを有する新規なインスリン誘導体 |
DE102008003566A1 (de) | 2008-01-09 | 2009-07-16 | Sanofi-Aventis Deutschland Gmbh | Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil |
DE102008025007A1 (de) | 2008-05-24 | 2009-11-26 | Sanofi-Aventis Deutschland Gmbh | Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil |
DE102008025008A1 (de) | 2008-05-24 | 2009-11-26 | Sanofi-Aventis Deutschland Gmbh | Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil |
RS56632B1 (sr) | 2008-10-17 | 2018-03-30 | Sanofi Aventis Deutschland | Kombinacija insulina i glp-1-agonista |
ES2855146T3 (es) | 2009-11-13 | 2021-09-23 | Sanofi Aventis Deutschland | Composición farmacéutica que comprende un agonista de GLP-1, una insulina y metionina |
PT3345593T (pt) | 2009-11-13 | 2023-11-27 | Sanofi Aventis Deutschland | Composição farmacêutica compreendendo despro36exendina- 4(1-39)-lys6-nh2 e metionina |
HUE031181T2 (en) | 2010-08-30 | 2017-06-28 | Sanofi Aventis Deutschland | Use of AVE0010 for the manufacture of a medicament for the treatment of type 2 diabetes |
DK2739646T3 (en) | 2011-05-10 | 2018-02-26 | Stefan Hermann | COMPREHENSIVE BUFFER SYSTEM FOR RENATURING HUMAN PROINSULIN OR PROINSULIN DERIVATIVES |
US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
CN103917241A (zh) | 2011-08-29 | 2014-07-09 | 赛诺菲-安万特德国有限公司 | 用于2型糖尿病患者中的血糖控制的药物组合 |
AR087744A1 (es) | 2011-09-01 | 2014-04-16 | Sanofi Aventis Deutschland | Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa |
JP5858945B2 (ja) | 2012-03-15 | 2016-02-10 | アークレイ株式会社 | 酵素を用いた測定方法 |
JP6970615B2 (ja) | 2014-12-12 | 2021-11-24 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | インスリングラルギン/リキシセナチド固定比処方 |
TWI748945B (zh) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | 第2型糖尿病病患治療 |
TW201705975A (zh) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | 第2型糖尿病病患之治療 |
CN113631707A (zh) * | 2019-02-19 | 2021-11-09 | 普林斯顿大学理事会 | 折叠结构域和rna颗粒相关蛋白质结构域的光调节寡聚化和相分离的系统和方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4366246A (en) * | 1977-11-08 | 1982-12-28 | Genentech, Inc. | Method for microbial polypeptide expression |
US4431739A (en) * | 1979-11-05 | 1984-02-14 | Genentech, Inc. | Transformant bacterial culture capable of expressing heterologous protein |
US4769326A (en) * | 1980-02-29 | 1988-09-06 | The Regents Of The University Of California | Expression linkers |
US4652639A (en) * | 1982-05-06 | 1987-03-24 | Amgen | Manufacture and expression of structural genes |
JPS61264000A (ja) * | 1985-03-21 | 1986-11-21 | イミユネツクス コ−ポレイシヨン | 標識ペプチドによるタンパク質の合成 |
DE3526995A1 (de) * | 1985-07-27 | 1987-02-05 | Hoechst Ag | Fusionsproteine, verfahren zu ihrer herstellung und ihre verwendung |
-
1990
- 1990-08-27 GR GR900100635A patent/GR1005153B/el not_active IP Right Cessation
- 1990-08-27 IL IL9549590A patent/IL95495A/en active IP Right Grant
- 1990-08-28 KR KR1019920700456A patent/KR0159786B1/ko not_active IP Right Cessation
- 1990-08-28 IE IE312090A patent/IE903120A1/en not_active IP Right Cessation
- 1990-08-28 DE DE69032743T patent/DE69032743T2/de not_active Expired - Lifetime
- 1990-08-28 EP EP90912715A patent/EP0489780B1/en not_active Expired - Lifetime
- 1990-08-28 HU HUP9200674A patent/HU216069B/hu unknown
- 1990-08-28 PT PT95111A patent/PT95111B/pt not_active IP Right Cessation
- 1990-08-28 AT AT90912715T patent/ATE173018T1/de not_active IP Right Cessation
- 1990-08-28 WO PCT/US1990/004840 patent/WO1991003550A1/en active IP Right Grant
- 1990-08-28 AU AU62872/90A patent/AU638277B2/en not_active Expired
- 1990-08-28 ES ES90912715T patent/ES2124216T3/es not_active Expired - Lifetime
- 1990-08-28 DK DK90912715T patent/DK0489780T3/da active
- 1990-08-28 JP JP2512297A patent/JP3043803B2/ja not_active Expired - Lifetime
- 1990-08-28 CA CA002065146A patent/CA2065146C/en not_active Expired - Lifetime
- 1990-09-28 ZA ZA906839A patent/ZA906839B/xx unknown
-
1992
- 1992-02-27 NO NO920774A patent/NO308667B1/no not_active IP Right Cessation
- 1992-02-28 FI FI920923A patent/FI113183B/fi active
-
1998
- 1998-12-11 HK HK98113231A patent/HK1012026A1/xx not_active IP Right Cessation
-
2000
- 2000-05-03 CY CY0000013A patent/CY2168B1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
JPH05501799A (ja) | 1993-04-08 |
IL95495A (en) | 1996-10-16 |
HK1012026A1 (en) | 1999-07-23 |
FI920923A0 (fi) | 1992-02-28 |
DE69032743T2 (de) | 1999-06-17 |
IE903120A1 (en) | 1991-03-13 |
NO308667B1 (no) | 2000-10-09 |
AU638277B2 (en) | 1993-06-24 |
KR0159786B1 (ko) | 1998-11-16 |
AU6287290A (en) | 1991-04-08 |
NO920774L (no) | 1992-04-28 |
HUT60327A (en) | 1992-08-28 |
HU216069B (hu) | 1999-04-28 |
GR1005153B (el) | 2006-03-13 |
ES2124216T3 (es) | 1999-02-01 |
HU9200674D0 (en) | 1992-08-28 |
GR900100635A (el) | 1991-12-30 |
DE69032743D1 (de) | 1998-12-10 |
PT95111A (pt) | 1991-05-22 |
CA2065146C (en) | 2002-07-23 |
EP0489780A4 (en) | 1992-08-12 |
NO920774D0 (no) | 1992-02-27 |
CY2168B1 (en) | 2002-08-23 |
EP0489780B1 (en) | 1998-11-04 |
EP0489780A1 (en) | 1992-06-17 |
DK0489780T3 (da) | 1999-07-19 |
FI113183B (fi) | 2004-03-15 |
IL95495A0 (en) | 1991-06-30 |
WO1991003550A1 (en) | 1991-03-21 |
CA2065146A1 (en) | 1991-03-01 |
ATE173018T1 (de) | 1998-11-15 |
PT95111B (pt) | 1998-10-30 |
JP3043803B2 (ja) | 2000-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL95495A0 (en) | Fusion proteins,their preparation and use | |
IL173399A0 (en) | Circular dna molecule with conditional origin of replication which contains nucleic acid of interest and selection marker but does not encode its replication initiation protein, method for preparing the same and use thereof in gene therapy | |
ATE88501T1 (de) | Rekombinante dns-expressionsvektoren. | |
AU6569386A (en) | Eukaryotic fusion proteins, the preparation and use thereof and means for carrying out the process | |
GR3020819T3 (en) | Toxoplasma gondii antigen, its production and use | |
ES8506347A1 (es) | Un metodo para producir un polipeptido de tipo il-2-". | |
IL81018A (en) | Fusion proteins comprising small fragments of human interleukin-2 as ballast,process for its preparation and genes,vectors and transformed host containing said fragments and used in the process | |
RU93045577A (ru) | Слитные полипептиды | |
ATE419357T1 (de) | Dna 19355 polypeptide, ein homolog des tumornekrosefaktors | |
AU3346289A (en) | Heparin-binding proteins, DNA coding for them, processes for producing them as well as therapeutic preparations containing them | |
JPS6420095A (en) | Polypeptide having anti-blood coagulating action | |
EP0395706A4 (en) | Production of gonorrheal pi proteins and vaccines | |
DE69634757D1 (de) | Vektor zur expression von n-terminal verlängerten proteinen in hefezellen | |
HUT40164A (en) | Process for preparing signal sequency for the transformation of proteins in expression systems | |
JPS6427473A (en) | Human pancreas-secreting trypsin inhibitor and production thereof | |
IL78278A0 (en) | Process for the production of polypeptides,dna sequence encoding desired polypeptide human somatomedin c polypeptide and recombinant dna molecules | |
JPS6474989A (en) | Dna to code human lysozyme | |
JPS6474988A (en) | Synthetic gene of cystatin c, corresponding recombinant plasmid and recombinant | |
IT1243286B (it) | Processo per isolamento ed espressione del fattore neuronotrofico ciliare umano mediante la tecnologia del dna ricombinante. | |
TH11697EX (th) | วิธีเตรียมพลาสมิดที่มีทั้งความสามารถในการแสดงลักษณะของรีโทรไวรัสจีนและความสามารถในการตบแต่ง |